Are you Dr. Richardson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Wade Ave
Catonsville, MD 21228Phone+1 410-402-6871Fax+1 410-402-6880
Summary
- Dr. Charles Richardson, MD is a board certified psychiatrist in Catonsville, Maryland. He is currently licensed to practice medicine in Maryland, Arizona, and Pennsylvania. He is affiliated with Spring Grove Hospital Center, University of Maryland Medical Center, and Johns Hopkins Howard County Medical Center.
Education & Training
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Psychiatry, 1985 - 1989
- University of North Carolina at Chapel Hill School of MedicineClass of 1985
Certifications & Licensure
- MD State Medical License 1989 - 2025
- AZ State Medical License 2009 - 2015
- PA State Medical License 1986 - 1990
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 4 citationsClozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial.Deanna L Kelly, Matthew Glassman, Ikwunga Wonodi, Gopal Vyas, Charles M Richardson
Schizophrenia Research. 2024-06-01 - 3 citationsAnti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness.Vincent S Cavaliere, Matthew Glassman, Bethany A DiPaula, Marie Mackowick, Heidi J Wehring
Schizophrenia Research. 2022-05-01 - 21 citationsRandomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility studyDeanna L. Kelly, Haley Demyanovich, Katrina Rodriguez, Daniela Cihakova, Monica V. Talor
Journal of Psychiatry & Neuroscience. 2019-07-01
Press Mentions
- TollereBio Advancing Vaccine Adjuvant Platform with Novel Technology Licensed from University of Maryland, BaltimoreFebruary 29th, 2024
- State Health Department Changes Research Policies at Spring Grove Psych HospitalJuly 2nd, 2024